Beyond HbA1c, Second Take

Journal of Diabetes - United States
doi 10.1111/1753-0407.12910
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Going Beyond HbA1C to Understand the Benefits of Advanced Diabetes Therapies

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

Correction To: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence Into Practice

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Continuing the Conversation: A Second Take on Innovative Elicitation Methods

International Journal of Qualitative Methods, The
Education
2019English

Laparoscopic Cholecystectomy: First, Do No Harm; Second, Take Care of Bile Duct Stones

Surgical Endoscopy
Surgery
2013English

MS18.04 Retreatment With Platinum and Etoposide and Treatment Beyond Second Line

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Systemic Treatment in EGFR-ALK NSCLC Patients: Second Line Therapy and Beyond

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Discordance Between HbA1c and Glycemia

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials

ACC Current Journal Review
2004English

How Does CKD Affect HbA1c?

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy